Atlas Trials

CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells

Clinical trial NCT01373047 · COMPLETED

Trial details

NCT number
NCT01373047
Sponsor
Roger Williams Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Liver Metastases
Start date
2011-06-01
Primary completion
2013-07-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.